Osaic Holdings
ALGS icon

Osaic Holdings’s Aligos Therapeutics ALGS Stock Holding History

Osaic Holdings’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-220
Closed -$1.59K – 7901
2025
Q2 		$1.59K Hold
220
– – ﹤0.01% 7019
2025
Q1 		$1.81K Sell
220
-675
-75% -$14.8K ﹤0.01% 6635
2024
Q4 		$35.7K Buy
895
+675
+307% +$13K ﹤0.01% 4939
2024
Q3 		$1.91K Hold
220
– – ﹤0.01% 6631
2024
Q2 		$1.93K Buy
+220
New +$3.87K ﹤0.01% 6610
2023
Q3 		– Sell
-320
Closed -$7.77K – 7386
2023
Q2 		$7.77K Hold
320
– – ﹤0.01% 6089
2023
Q1 		$6.99K Hold
320
– – ﹤0.01% 6180
2022
Q4 		$8K Hold
320
– – ﹤0.01% 6046
2022
Q3 		$9K Hold
320
– – ﹤0.01% 6053
2022
Q2 		$10K Hold
320
– – ﹤0.01% 6067
2022
Q1 		$17K Buy
320
+140
+78% +$11.2K ﹤0.01% 5792
2021
Q4 		$53K Hold
180
– – ﹤0.01% 5096
2021
Q3 		$70K Buy
+180
New +$71.2K ﹤0.01% 4831

Other funds holding ALGS

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings's ALGS Position: Q3 2025 in Review

Osaic Holdings sold out of Aligos Therapeutics (ALGS) in Q3 2025, closing a stake of 220 shares — an estimated $1.59K sold.

Osaic Holdings first reported a position in ALGS in Q3 2021 and held it in 13 quarters. The position peaked at $70K in Q3 2021. 33 funds tracked by Wall St. Rank hold ALGS as of Q3 2025.

  • Osaic Holdings reported no remaining Aligos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Osaic Holdings sold 220 Aligos Therapeutics shares in Q3 2025, an estimated $1.59K.
  • Osaic Holdings first reported a position in Aligos Therapeutics in Q3 2021 and held it in 13 quarters.
  • Osaic Holdings's Aligos Therapeutics position peaked at $70K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q3 2025.

Based on Osaic Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.